Medicines eligible for Northern Ireland MHRA Authorised Route

This document lists the medicines eligible for supply through the Northern Ireland MHRA Authorised Route (NIMAR).

The listed medicines may be dispatched from Great Britain to Northern Ireland on the basis of the medicine’s authorisation in Great Britain.

This list is maintained and published in accordance with regulation 167B (list of NIMAR products) of the Human Medicines Regulations 2012 (SI 2012/1916, as amended).

Updated to remove products from the list. Removed: Filsuvez gel; and Talzenna 1mg capsules - Talazoparib 1mg capsules.

Updated to remove products from the list. Removed: Atriance 250mg/50ml solution for infusion vials - Nelarabine 250mg/50ml solution for infusion vials; and Toremifine 60mg tablets.

Updated to remove: Doxepin 5% cream.

Updated to remove: Acetylcysteine 200mg oral powder sachets sugar free.

Updated to remove products from the list. Removed: Basiliximab 10mg powder and solvent for solution for injection vials; Zarzio 30 million units/0.5ml solution for injection pre-filled syringes - Filgrastim 30 million units/0.5ml solution for injection pre-filled syringes.

Updated to add: Atriance 250mg/50ml solution for infusion vials - Nelarabine 250mg/50ml solution for infusion vials.

Updated to remove products from the list. Removed: Xofluza 80mg tablets - Baloxavir marboxil 80mg tablets; Canagliflozin 50mg/Metformin 850mg tablets; Lantus 100units/ml solution for injection 10ml vials - Insulin glargine 100units/ml solution for injection 10ml vials; Nelarabine 5mg/ml solution for infusion.

Updated to remove products from the list. Removed: Dapagliflozin 5mg/Metformin 1g tablets; Metronidazole 0.75% gel; Epistatus 2.5mg/0.25ml oromucosal solution pre-filled oral syringes - Midazolam 2.5mg/0.25ml oromucosal solution pre-filled oral syringes sugar free; Imvanex vaccine suspension for injection 0.5ml vials - Smallpox vaccine (live) suspension for injection 0.5ml vials; Xermelo 250mg tablets - Telotristat 250mg tablets; Topotecan 4mg/4ml concentrate for solution for infusion vials.

Updated to remove products from the list. Removed: Acetylcholine chloride 20mg powder and solvent for solution for intraocular irrigation ampoules; Ibandronic acid 50mg tablets; Kalydeco 13.4 mg granules in sachet - Ivacaftor 13.4mg granules; Mobocertinib 40mg capsules; Oxybutynin 3.9mg/24hours transdermal patches; and Sodium chloride 0.18% + glucose 4% infusion bags.

Updated to remove: Sucralfate 1g/5ml liquid (sugar free).